Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Resident, Medicine, Duke University 2004 - 2008
  • M.D., Washington University 2004
• 

  Duke Appointment History

  • Medical Instructor in the Department of Medicine, Medicine, General Internal Medicine, Medicine 2008 - 2011
• Publications & Artistic Works
• 

  Selected Publications

  • Conference Papers

    • Chudgar, S, McManigle, WC, Graham, AJ, Bae, J, Setji, NP, and O'Brien, CL. "TEACHING ESSENTIAL SKILLS: TRAINING MEDICAL STUDENTS IN QUALITY IMPROVEMENT, PROCEDURES, AND TRANSITIONS OF CARE." June 2013.  Link to Item

  • Journal Articles

    • Rhee, C, Filbin, MR, Massaro, AF, Bulger, AL, McEachern, D, Tobin, KA, Kitch, BT, Thurlo-Walsh, B, Kadar, A, Koffman, A, Pande, A, Hamad, Y, Warren, DK, Jones, TM, O'Brien, C, Anderson, DJ, Wang, R, Klompas, M, and Centers for Disease Control and Prevention (CDC) Prevention Epicenters Program, . "Compliance With the National SEP-1 Quality Measure and Association With Sepsis Outcomes: A Multicenter Retrospective Cohort Study." Critical Care Medicine 46, no. 10 (October 2018): 1585-1591.  Full Text
    • Bedoya, AD, Clement, ME, Phelan, M, Steorts, RC, O'Brien, C, and Goldstein, BA. "Minimal Impact of Implemented Early Warning Score and Best Practice Alert for Patient Deterioration." Critical Care Medicine (September 21, 2018).  Full Text
    • Rhee, C, Brown, SR, Jones, TM, O'Brien, C, Pande, A, Hamad, Y, Bulger, AL, Tobin, KA, Massaro, AF, Anderson, DJ, Warren, DK, Klompas, M, and CDC Prevention Epicenters Program, . "Variability in determining sepsis time zero and bundle compliance rates for the centers for medicare and medicaid services SEP-1 measure." Infection Control and Hospital Epidemiology 39, no. 8 (August 2018): 994-996.  Full Text
    • O'Brien, CL, and Gage, BF. "Cost-effectiveness of ximelagatran for stroke prevention - In reply." JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 293, no. 23 (June 15, 2005): 2861-2861.  Full Text  Link to Item
    • O'Brien, CL, and Gage, BF. "Costs and effectiveness of ximelagatran for stroke prophylaxis in chronic atrial fibrillation." JAMA 293, no. 6 (February 9, 2005): 699-706.  Full Text  Link to Item
    • Perret-Guillaume, C, Wahl, D, O'Brien, CL, and Gage, BF. "Cost-effectiveness of ximelagatran for stroke prevention [2] (multiple letters)." Journal of the American Medical Association 293, no. 23 (2005): 2860-2861.  Full Text
    • Brendza, RP, O'Brien, C, Simmons, K, McKeel, DW, Bales, KR, Paul, SM, Olney, JW, Sanes, JR, and Holtzman, DM. "PDAPP; YFP double transgenic mice: A tool to study amyloid-β associated changes in axonal, dendritic, and synaptic structures." Journal of Comparative Neurology 456, no. 4 (2003): 375-383.  Full Text

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.